Description
cagrilintide novo nordisk announced on February 23, 2026, that its next-generation obesity drug CagriSema — one of the company's most critical pipeline assets — failed to outperform Eli Lilly's tirzepatide (Zepbound) in a lab research capsules Choose Your Bundle:16oz | 10 Pack HCG Injectable — Restorative
HCG Injectable — Restorative Compounding Pharmacy + Wellness
Third-party tested for purity, ID, quantity
lab research capsules
Choose Your Bundle:16oz | 10 Pack
Any noticeable change during room-temperature storage warrants extra scrutiny